Abstract
In an effort to explore new knowledge and to develop meaningful collaborations for improving child health, the First Pan African Workshop on Newborn Screening was convened in June 2019 in Rabat, Morocco. Participants included an informal network of newborn screening stakeholders from across Africa and global experts in newborn screening and sickle cell disease. Over 150 attendees, representing 20 countries, were present including 11 African countries. The agenda focused on newborn screening rationale, techniques, system development, implementation barriers, ongoing research, and collaborations both globally and across Africa. We provide an overview of the workshop and a description of the newborn screening activities in the 11 African countries represented at the workshop, with a focus on sickle cell disease.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Abbreviations
- ACMG:
-
American College of Medical Genetics and Genomics
- AfroSickleNet:
-
Africa Sickle Cell Research Network
- AMDNNPH:
-
Moroccan Society for Newborn Screening and Handicap Prevention
- APHL:
-
Association of Public Health Laboratories (U.S.)
- App:
-
Mobile application (telephone, etc.)
- BCG:
-
Bacillus Calmette–Guérin
- CCP:
-
Comprehensive care program
- CDC:
-
Centers for Disease Control and Prevention (U.S.)
- CH:
-
Congenital hypothyroidism
- CNRST:
-
National Center for Scientific and Technological Research (Morocco)
- EID:
-
Early infant diagnosis
- GAVI:
-
Global Alliance for Vaccines and Immunization
- H3Africa:
-
Human Heredity and Health in Africa
- Hb:
-
Hemoglobin
- HIV:
-
Human immunodeficiency virus
- HPLC:
-
High performance liquid chromatography
- IAEA:
-
International Atomic Energy Agency
- IEF:
-
Isoelectric focusing
- IMR:
-
Infant mortality rate (under 1 year)
- ISNS:
-
International Society for Neonatal Screening
- MDG:
-
Millennium development goal
- MENA:
-
Middle East North Africa
- MoH:
-
Ministry of Health
- NBS:
-
Newborn screening
- NIH:
-
National Institutes of Health (U.S.)
- NNSGRC:
-
National Newborn Screening and Global Resource Center (U.S.)
- SCA:
-
Sickle cell anemia (SCD-SS)
- SCD:
-
Sickle cell disease (group of diseases associated with Hb S)
- SCDIC:
-
Sickle cell disease implementation consortium
- SCD-SC:
-
Sickle cell disease SC
- SCT:
-
Sickle cell trait (sickle gene carrier, AS)
- SDG:
-
Sustainable Development Goal
- SCCAN:
-
Sickle Cell Carers Awareness Network
- UN:
-
United Nations
- U5MR:
-
Under 5-year mortality rate
- UNICEF:
-
United Nations International Children’s Emergency Fund (now called the UN Children’s Fund)
- US3:
-
Uganda Sickle Surveillance Study
- WHO:
-
World Health Organization
References
Adegoke SA, Akinlosotu MA, Adediji OB, Oyelami OA, Adeodu OO, Adekile AD (2018) Sickle cell disease in southwestern Nigeria: assessment of knowledge of primary health care workers and available facilities. Trans R Soc Trop Med Hyg 112(2):81–87
Aderotoye-Oni S, Diaku-Akinwumi IN, Adeniran A, Falase B (2018) Unprepared and misinformed parents of children with sickle cell disease: time to rethink awareness campaigns. Cureus 10(12):e3806
Anie KA, Treadwell MJ, Grant AM (2016) Community engagement to inform the development of a sickle cell counselor training and certification program in Ghana. J Community Genet 7:195–202
Belhassan K, Ouldim K, Selfiani AA (2016) Genetics and genomic medicine in Morocco: the present hope can make the future bright. Mol Genet Genomic Med 4(6):588–598
Bukini D, deVries J, Treadwell M, Anie K, Dennis-Antwi J, Kamga KK, McCurdy S, Ohene-Frempong K, Makani J, Wonkam A (2019) Exploring the role of shared decision making in the consent process for pediatric genomics research in Cameroon, Tanzania, and Ghana. AJOB Empir Bioeth 10(3):182–189
Burnham-Marusich AR, Ezeanolue CO, Obiefune MC, Yang W, Osuji A, Ogidi AG, Hunt AT, Patel D, Ezeanolue EE (2016) Prevalence of sickle cell trait and reliability of self-reported status among expectant parents in Nigeria: implications for targeted newborn screening. Public Health Genomics 19(5):298–306
Chaturvedi S, DeBaun MR (2016) Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years. Am J Hematol 91:5–14
Chindima N, Nkhoma P, Sinkala M, Zulu M, Kafita D, Simakando M, Mwaba F, Mantina H, Mutale M (2018) The use of dried blood spots: a potential tool for the introduction of a neonatal screening program for sickle cell anemia in Zambia. Int J Appl Basic Med Res 8:30–32
Dennis-Antwi JA, Ohene-Frempong K, Anie KA et al (2018) Relation between religious perspectives and views on sickle cell disease research and associated public health interventions in Ghana. J Genet Couns. https://doi.org/10.1007/s10897-018-029607
Diallo DA, Guindo A, Touré BA et al (2018) Targeted newborn screening for sickle-cell anemia: sickling test (Emmel test) boundaries in the prenatal assessment in West African area. Rev Epidemiol Sante Publique 66(3):181–185 [Article in French]
DiMartino LD, Baumann AA, Hsu LL et al (2018) The sickle cell disease implementation consortium: translating evidence-based guidelines into practice for sickle cell disease. Am J Hematol 93(12):E391–E395
Ejiofor OS, Efobi C, Emechebe GO et al (2018) Newborn screening for sickle cell disease (SCD) in Awka South East Nigeria. J Blood Disord Transfus 9:398
Evans A, Bonhomme N, Goodman A, Terry SF (2018) Newborn screening and health communications. Genet Test Mol Biomarkers 22(9):507–508
Forman J, Coyle F, Levy-Fisch J, Roberts P, Terry S, Legge M (2013) Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening. J Community Genet 4(1):59–67
Glidewell J, Grosse SD, Riehle-Colarusso T, Pinto N, Hudson J, Daskalov R, Gaviglio A, Darby E, Singh S, Sontag M (2019) Actions in support of newborn screening for critical congenital heart disease - United States, 2011-2018. MMWR Morb Mortal Wkly Rep 68(5):107–111
Green NS, Mathur S, Kiguli S et al (2016) Family, community, and health system considerations for reducing the burden of pediatric sickle cell disease in Uganda through newborn screening. Glob Pediatr Health 3:2333794X16637767
Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN (2011) Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 41:S398–S405
H3Africa Consortium, Rotimi C, Abayomi A et al (2014) Research capacity. Enabling the genomic revolution in Africa. Science 344(6190):1346–1348
Hafiani K, Bazoui H, El Madhi Y et al (2017) Major sickle cell syndromes in children in Kenitra, Morocco. Asian Pac J Trop Dis 7(11):688–690
Hinton CF, Feuchtbaum L, Kus CA, Kemper AR, Berry SA, Levy-Fisch J, Luedtke J, Kaye C, Boyle CA (2011) What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services’ Advisory Committee on Heritable Disorders in Newborns and Children. Genet Med 13(10):861–865
Howson CP, Cedergren B, Giugliani R, Huhtinen P, Padilla CD, Palubiak CS, Santos MD, Schwartz IVD, Therrell BL, Umemoto A, Wang J, Zeng X, Zhao X, Zhong N, McCabe ERB (2018) Universal newborn screening: a roadmap for action. Mol Genet Metab 124(3):177–183
Hsu L, Nnodu OE, Brown BJ et al (2018) White paper: pathways to progress in newborn screening for sickle cell disease in sub-Saharan Africa. J Trop Dis Pub Health 6(2):260
International Society of Nurses in Genetics (2019) Advancing sickle cell disease care and research in Sierra Leone. Cheedy Jaja. https://isong.wildapricot.org/page-1325179 (accessed 1 December 2019)
Inusa BP, Daniel Y, Lawson JO et al (2015) Sickle cell disease screening in Northern Nigeria: the co-existence of β-thalassemia inheritance. Pediat Therapeut 5:3
Inusa BP, Anie KA, Lamont A et al (2018) Utilising the ‘Getting to Outcomes’ framework in community engagement for development and implementation of sickle cell disease newborn screening in Kaduna State, Nigeria. Int J Neonatal Scr 4(4):33
Kafando E, Nacoulma E, Ouattara Y, Ayeroue J, Cotton F, Sawadogo M, Gulbis B (2009) Neonatal haemoglobinopathy screening in Burkina Faso. J Clin Pathol 62(1):39–41
Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP (2018) Sickle cell disease. Nat Rev Dis Primers 4:18010
Kiyaga C, Hernandez AG, Ssewanyana I, McElhinney KE, Ndeezi G, Howard TA, Ndugwa CM, Ware RE, Aceng JR (2018) Building a sickle cell disease screening program in the Republic of Uganda: the Uganda Sickle Surveillance Study (US3) with 3 years of follow-up screening results. Blood Adv 2(Suppl 1):4–7
Kiyaga C, Hernandez AG, Ssewanyana I, Schaefer BA, McElhinney K, Ndeezi G, Howard TA, Ndugwa CM, Ware RE, Aceng JR (2019) Sickle cell screening in Uganda: high burden, human immunodeficiency virus comorbidity, and genetic modifiers. Pediatr Blood Cancer 66(8):e27807
Krotoski D, Namaste S, Raouf RK, el Nekhely I, Hindi-Alexander M, Engelson G, Hanson JW, Howell RR, MENA NBS Steering Committee (2009) Conference report: second conference of the Middle East and North Africa newborn screening initiative: partnerships for sustainable newborn screening infrastructure and research opportunities. Genet Med 11(9):663–668
Kulkarni AG, Jekeme SD (1986) Cord blood screening for haemoglobinopathies in northern Nigeria. Ann Trop Med Parasitol 80(5):549–551
Kuznik A, Habib AG, Munube D, Lamorde M (2016) Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis. BMC Health Serv Res 16:304
Laghmich A, Alaoui Ismaili FZ, Barakat A, Ghailani Nourouti N, Bennani Mechita M (2019a) Alpha-thalassemia in North Morocco: prevalence and molecular spectrum. Biomed Res Int 2019:2080352
Laghmich A, Alaoui Ismaili FZ, Barakat A, Ghailani Nourouti N, Bennani Mechita M (2019b) Hamoglobinopathies in the north of Morocco: consanguinity pilot study. Biomed Res Int 2019:6857417
Lloyd-Puryear M, Brower A, Berry SA, Brosco JP, Bowdish B, Watson MS (2019) Foundation of the Newborn Screening Translational Research Network and its tools for research. Genet Med 21(6):1271–1279
Makani J, Cox SE, Soka D et al (2011) Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS One 6(2):e14699
Makani J, Soka D, Rwezaula S, Krag M, Mghamba J, Ramaiya K, Cox SE, Grosse SD (2015) Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality. Tropical Med Int Health 20(2):184–187
Malawi GNI per capita 1962-2019. https://www.macrotrends.net/countries/MWI/malawi/gni-per-capita (accessed 1 December 2019)
McCabe LL, Therrell BL, McCabe ERB (2002) Newborn screening: rationale for a comprehensive, fully integrated public health system. Molec Genet Metabol 77:267–273
McGann PT, Hoppe C (2017) The pressing need for point-of-care diagnostics for sickle cell disease: a review of current and future technologies. Blood Cells Mol Dis 67:104–113
McGann PT, Ferris MG, Ramamurthy U et al (2013) A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola. Am J Hematol 88(12):984–989
McGann PT, Grosse SD, Santos B et al (2015) A cost-effectiveness analysis of a pilot neonatal screening program for sickle cell anemia in the Republic of Angola. J Pediatr 167(6):1314–1319
McGann PT, Hernandez AG, Ware RE (2017) Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood 129(2):155–161
Ministry of Health Morocco (2018) Plan Santé 2025. (see Action 65, Measure 65.2)
Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, Nsungwa J, Kiguli S, Ndugwa CM, Ware RE, Aceng JR (2016) Burden of sickle cell trait and disease in the Uganda sickle surveillance study (US3): a cross-sectional study. Lancet Glob Health 4(3):e195–e200
Nkya S, Mtei L, Soka D, Mdai V, Mwakale PB, Mrosso P, Mchoropa I, Rwezaula S, Azayo M, Ulenga N, Ngido M, Cox SE, D’Mello BS, Masanja H, Kabadi GS, Mbuya F, Mmbando B, Daniel Y, Streetly A, Killewo J, Tluway F, Lyimo M, Makani J (2019) Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania. Int Health 11(6):589–595
Nnodu OE (2014) Interventions for the prevention and control of sickle cell disease at primary health care centres in Gwagwalada Area Council of the Federal Capital Territory, Nigeria. Cureus 6(8):e194. https://doi.org/10.7759/cureus.194
Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A (2019) HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: promises and challenges. Blood Cells Mol Dis 78:22–28
Nwegbu MM, Isa HA, Nwankwo BB (2017) Preliminary evaluation of a point-of-care testing device (SickleSCAN) in screening for sickle cell disease. Hemoglobin 41(2):77–82
Obed SA, Asah-Opoku K, Aboagye S et al (2017) Awareness of sickle cell trait status: a cross-sectional survey of antenatal women in Ghana. Am J Trop Med Hyg 96(3):735–740
Odame I, Kulkarni R, Ohene-Frempong K (2011) Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana. Am J Prev Med 41(6 Suppl 4):S417–S421
Odunvbun ME, Okolo AA, Rahimy CM (2008) Newborn screening for sickle cell disease in a Nigerian hospital. Public Health 122(10):1111–1116
Ohene-Frempong K, Oduro J, Tetteh H, Nkrumah F (2008) Screening newborns for sickle cell disease in Ghana. Pediatrics121:S120–S121
Ojewunmi OO, Adeyemo TA, Ayinde OC, Iwalokun B, Adekile A (2019) Current perspectives of sickle cell disease in Nigeria: changing the narratives. Expert Rev Hematol 12(8):609–620
Ojodu J, Hulihan MM, Pope SN, Grant AM (2014) Incidence of sickle cell trait--United States, 2010. MMWR Morb Mortal Wkly Rep 63(49):1155–1158
Oster ME, Aucott SW, Glidewell J et al (2016) Lessons learned from newborn screening for critical congenital heart defects. Pediatrics 137(5):e20154573
Padilla CD, Krotoski D, Therrell BL (2010) Newborn screening progress in developing countries – overcoming internal barriers. Semin Perinatol 34:145–155
Padilla CD, Therrell BL, Working Group of the Asia Pacific Society for Human Genetics on Consolidating Newborn Screening Efforts in the Asia Pacific Region (2012) Consolidating newborn screening efforts in the Asia Pacific region: networking and shared education. J Community Genet 3:35–45
Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN (2013a) Global burden of sickle cell anaemia in children under five, 2010–2050: modeling based on demographics, excess mortality, and interventions. PLoS Med 10:e1001484
Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN, Weatherall DJ, Hay SI (2013b) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381(9861):142–151
Rahimy MC, Gangbo A, Ahouignan G, Alihonou E (2009) Newborn screening for sickle cell disease in the Republic of Benin. J Clin Pathol 62(1):46–48
Rwezaula SS, Magesa PM, Mgaya J et al (2015) Newborn screening for hemoglobinopathies at Muhimbili National Hospital, Dar es Salaam – Tunisia. E Afr J Pub Health 12(1):948–955
Shook LM, Ware RE (2018) Effective screening leads to better outcomes in sickle cell disease. Arch Dis Child 103(7):628–630
Sierra Leone Ministry of Health and Sanitation (2018) Sierra Leone National Multi-Sectoral Strategy to Prevent and Control Anaemia 2018–2025. https://www.afro.who.int/sites/default/files/2018-03/National%20Multi-Sectoral%20Strategy%20to%20Prevent%20and%20Control%20Anaemia%20%282018-2025%29.pdf (accessed 1 Dece 2019)
Smart LR, Hernandez AG, Ware RE (2018) Sickle cell disease: translating clinical care to low-resource countries through international research collaborations. Semin Hematol 55(2):102–112
Solanki KK (2007) Training programs for developing countries. J Inherit Metab Dis 30(4):596–599
Streetly A, Sisodia R, Dick M, Latinovic R, Hounsell K, Domandy E (2018) Evaluation of newborn sickle cell screening programme in England: 2010-2016. Arch Dis Child 103(7):648–653
Therrell BL (2001) U.S. newborn screening policy dilemmas for the twenty-first century. Mol Genet Metab 74(1–2):64–74
Therrell BL, Hannon WH (2006) National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev 12(4):236–245
Therrell BL, Padilla CD (2005) Screening of newborns for congenital hypothyroidism. International Atomic Energy Agency, Vienna
Therrell BL, Padilla CD (2014) Barriers to implementing sustainable national newborn screening in developing health systems. Int J Pediatr Adolesc Med 1:49–60
Therrell BL, Schwartz M, Southard C et al (2010) Newborn Screening Performance Evaluation Assessment Scheme (PEAS). Sem Perinatol 34(2):105–120
Therrell BL, Lloyd-Puryear MA, Eckman JR, Mann MY (2015a) Newborn screening for sickle cell diseases in the United States: a review of data spanning 2 decades. Semin Perinatol 39(3):238–251
Therrell BL, Padilla CD, Loeber JG, Khneisser I, Saadallah A, Borrajo GJC, Adams J (2015b) Current status of newborn screening worldwide: 2015. Semin Perinatol 39:171–187
Treadwell MJ, Anie KA, Grant AM, Ofori-Acquah SF, Ohene-Frempong K (2015) Using formative research to develop a counselor training program for newborn screening in Ghana. J Genet Couns 24(2):267–277
Tshilolo L, Kafando E, Sawadogo M, Cotton F, Vertongen F, Ferster A, Gulbis B (2008) Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health 122(9):933–941
Tshilolo L, Aissi LM, Lukusa D, Kinsiama C, Wembonyama S, Gulbis B, Vertongen F (2009) Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31,204 newborns. J Clin Pathol 62(1):35–38
Tshilolo L, Tomlinson G, Williams TN, Santos B, Olupot-Olupot P, Lane A, Aygun B, Stuber SE, Latham TS, McGann P, Ware RE, REACH Investigators (2019) Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa. N Engl J Med 380(2):121–131
Tubman VN, Marshall R, Jallah W, Guo D, Ma C, Ohene-Frempong K, London WB, Heeney MM (2016) Newborn screening for sickle cell disease in Liberia: a pilot study. Pediatr Blood Cancer 63:671–676
U.S. Census Bureau (2020) World population review - fertility. http://worldpopulationreview.com/countries/total-fertility-rate/ (Accessed 9 Jan 2020)
UNICEF (2008) The State of the World’s Children 2008: child survival. https://www.unicef.org/publications/files/The_State_of_the_Worlds_Children_2008.pdf (accessed 1 Dec 2019)
UNICEF (2019) The State of the World’s Children 2019 Statistical Tables. https://data.unicef.org/resources/dataset/sowc-2019-statistical-tables/ ()
United Nations (2008) General Assembly Resolution 63/237. Recognition of sickle cell anaemia as a public health problem Adopted 22 Dec 2008. https://digitallibrary.un.org/record/644334?ln=en (accessed 1 Dec 2019)
United Nations (2019) World Population Prospects 2019: Data Booklet (ST/ESA/SER.A/424). https://population.un.org/wpp/Publications/Files/WPP2019_DataBooklet.pdf (accessed 1 Dec 2019)
Wastenedge E, Waters D, Patel S et al (2018) The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis. J Glob Health 8(2):021103. https://doi.org/10.7189/jogh.08.021103
Weatherall DJ (2011) The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol 154(6):736–744
WHO Regional Committee for Africa (2011) Sickle-cell disease: a strategy for the WHO African Region. https://apps.who.int/iris/handle/10665/1682 (Accessed 20 Jan 2010)
Wonkam A, Makani J, Ofori-Aquah S, Nnodu OE, Treadwell M, Royal C, Ohene-Frempong K, Members of the H3Africa Consortium (2015) Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients. Cardiovasc J Afr 26(2 Suppl 1):S50–S55
World Health Organization (2006) Sickle-cell anemia: report by the Secretariat. http://apps.who.int/gb/archive/pdf_files/wha59/a59_9-en.pdf (Accessed 1 Dec 2019)
World Health Organization (2009) Newborn and infant hearing screening: current issues and guiding principals for action. https://www.who.int/blindness/publications/Newborn_and_Infant_Hearing_Screening_Report.pdf?ua=1 (Accessed 15 Sept 2019)
World Health Organization (2010) Birth defects. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R17-en.pdf (Accessed 1 Dec 2019)
Yarhere IE, Jaja T, Briggs D, Iughetti L (2019) Newborn screening in Nigeria: associating the screening of congenital hypothyroidism and sickle cell disease can be a winning choice? Acta Biomed 90(2):316–320
Yusuf C, Sontag MK, Miller J et al (2019) Development of national newborn screening quality indicators in the United States. Int J Neonatal Screen 5(3):34
Acknowledgments
Meeting faculty and speakers included (alphabetically) Zilfalil Bin Alwi, Malaysia; Emmanuela E. Ambrose, Tanzania; Kofie Anie, United Kingdom; Augustine K. Asubonteng, Ghana; Amina Barkat, Morocco; Natasha Bonhomme, USA; Jackie Boucher; USA; Fenna Builler, Morocco; Layachi Chabraoui, Morocco; Etienne Dembele, Mali; Nouzha Dghoughi, Morocco; Olav Eielsen, Norway; Hassan Ghazal, Morocco; R. Rodney Howell, USA; Sara El Janahi, Morocco; Issam Khneisser, Lebanon; Charles Kiyaga, Uganda; Achraf Laghmich, Morocco; Jill Levy-Fisch, USA; Michele A. Lloyd-Puryear, USA; Fred Lorey, USA; Ana Marcão, Portugal; Gerard Martin, USA; Fred Meindl, USA; Tisungane Mvalo, Malawi; Obiageli E. Nnodu, Nigeria; Kwaku Ohene-Frempong, USA/Ghana; Karim Ouldim, Morocco; Afia Asamoah Owusu, Ghana; Carmencita D. Padilla, Philippines; Mohamed Chérif Rahimy, Benin; Brígida Santos, Angola; Annamarie Saarinen, USA; Nadia El Idrissi Slitine, Morocco; Bradford L. Therrell, Jr., USA; Peter J. Tonellato, USA; Léon Tshilolo, Democratic Republic of Congo; Lisa A. Wandler, USA, Russell E. Ware, USA; Michael S. Watson, USA; Raquel Yahyaoui, Spain; Careema Yusuf, USA; Guisou Zarbalian, USA.
Thanks are extended to the following colleagues, deans, and directors that supported the event and significantly contributed to its success: Zakia Sebbane, (Morocco MoH), Abdelhakim Yahyane (Morocco MoH), Mohamed Khalfaoui (CNRST, Rabat), Ahmed Hammouch, (Morocco Ministry of Higher Education and Research), Abderrahmane Maaroufi (Institut Pasteur Maroc), Mohamed Cherkaoui (Institut Pasteur Maroc), Chakib Nejjari (University Mohamed VI for Health Sciences, Casablanca), Mohamed Rajaoui (National Institute of Health, Rabat), Mohamed Benlemlih (School of Sciences, Fes), Khalid El Bikri (Enset School of Engineering, Rabat), Hamid El Amri (Royal Institute of Genetics, Rabat), Mohamed El Azami El Idrissi (School of Medicine, Fes), Adil Ibrahimi (School of Medicine, Fes), Abdelkhalek Legssyer (School of Sciences, Oujda), Noureddine Boukhatem (School of Sciences, Oujda), Samir Kaddar (C3M, Brussels), Michele A. Lloyd-Puryear (USA), Russell E. Ware (USA), Bradford L. Therrell, Jr. (USA), Michael S. Watson (USA), R. Rodney Howell (USA), Kwaku Ohene-Frempong (USA/Ghana) Martin Gerard (USA), Clement McDonald (USA).
Specials thanks for significant contributions to the meeting organization go to the following colleagues in Morocco: Salsabil Hamdi, Hayat Sedrati, Mohamed Benazzouz, Naima Erreimi, Asmae Tantane, Hicham Sam, Abderrazak Rfaki, Hicham Bekkari, Zineb Mohsine, Abdellah Idrissi Azami, Wajih Rhalem, Mourad Raji, Sofia Sehli, Nihal Habib, Chaimae Samtal, Zineb El Otmani, Manal Chrairi, Ferdaous Idlahcen, Samira Zguiti, Fatiha Haddad, Souad Chaqsar, Sahar El Kasmi and Hanae Belghiti.
The primary meeting organizer was the Moroccan Society for Newborn Screening and Handicap Prevention in partnership with: National Center for Scientific and Technological Research, Rabat, Morocco; Population Department, Ministry of Health, Rabat, Morocco; International Society for Neonatal Screening; Pasteur Institute of Morocco, Casablanca; National Institute of Health, Rabat, Morocco; American College of Medical Genetics and Genomics, MD, USA; US National Library of Medicine, MD, USA; Children’s National Medical Center, Washington, DC, USA; Newborn Foundation, USA; Association of Public Health Laboratories, USA; National Newborn Screening and Global Resource Center, USA. Collaborators included: Save Babies Through Screening Foundation, USA; Genetic Alliance, USA; School of Sciences of Oujda; School of Medicine of Fes; School of Sciences of Fes; School of Engineering Enset, Rabat; Association of Moroccan Physicians Abroad (C3M); and Children’s HeartLink, USA.
Funding
Meeting funding was provided by: Perkin Elmer, Masimo, Bio-Rad, International Society for Neonatal Screening, Laboratoires Afric-Phar, Zen Tech, Genome Biotechnologies, Mabiotech, Sanofi, Association of Public Health Laboratories, Tibo Medicals, and the American College of Medical Genetics and Genomics.
Author information
Authors and Affiliations
Consortia
Contributions
All authors contributed to the study conception and design. The first draft of the manuscript was written by Dr. Bradford L. Therrell, Jr. in collaboration with Dr. Michele A. Lloyd-Puryear. Primary additions and revisions were provided by Dr. Kwaku Ohene-Frempong, Dr. Russell E. Ware, Dr. Carmencita D. Padilla and Dr. Michael S. Watson. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix 1 2019 Rabat Declaration on Newborn Screening
Appendix 1 2019 Rabat Declaration on Newborn Screening
Preamble
The First Pan African Newborn Screening Workshop occurred in Rabat, Morocco, June 12–14, 2019 and included attendees from 11 African nations: Morocco, Angola, Benin, Democratic Republic of Congo, Ghana, Malawi, Mali, Nigeria, Sierra Leone, Tanzania, and Uganda in addition to countries in Europe, North America, and Asia/Pacific. International experts from around the world and in the region provided the human resources necessary to accomplish the meeting’s goal of exploring new knowledge and developing meaningful collaborations for improving child health by implementing sustainable newborn screening programs throughout Africa.
Early identification can be facilitated by screening newborns shortly after birth for congenital or genetic disorders that can result in major disabilities, when not managed early. In addition to benefits for the child and family, there are also significant benefits to society when early treatment can lead to productive individuals with a meaningful life whose long-term disability is not a lingering burden to families and society. Sickle cell disease (SCD) is a group of conditions, common in Africa, for which early identification and interventions lead to significantly improved health outcomes. The high prevalence of undiagnosed non-communicable diseases, including SCD, invariably contributes to excess mortality in children less than 5 years of age (Wastenedge et al. 2018). Each year, approximately 400,000 babies worldwide are born with SCD (Weatherall 2011), with more than 75% in sub-Saharan Africa, where it is estimated that 50 to 90% die before their 5th birthday (Grosse et al. 2011). The World Health Organization (WHO) and United Nations have designated SCD as a global public health problem. In addition to SCD, other important conditions to be considered by countries developing newborn screening programs include congenital hypothyroidism, phenylketonuria and the thalassemias.
In order to begin to address ways in which newborn screening for SCD and other congenital or genetic disorders may be established, we have sought to identify challenges to implementation of sustainable newborn screening programs and the ways in which our collective engagement can further our efforts to improve child health across the African continent. With regard to these issues, Workshop participants formulated the 2019 Rabat Declaration on Newborn Screening.
Declaration
Recognizing that newborn screening programs must function within local public health systems governed by political and societal realities in a given context;
Recognizing that there may be a need for substantial adaptations tailored to the local realities in order to accomplish the ultimate goals of early identification, treatment and enrollment into comprehensive care;
Recognizing that sub-Saharan Africa accounts for over 75% of the global SCD burden, and appreciating that a newborn screening panel can include many different congenital conditions,
-
We hereby affirm that hemoglobinopathy screening should be the major focus of newborn screening programs within sub-Saharan Africa;
-
All countries should endeavor to establish a NBS program within the context of their national health care system.
We have identified the following activities to promote sustainable newborn screening across Africa:
-
Engagement with Ministries of Health to boost awareness of need for newborn screening; to request endorsement of newborn screening; and to ensure alignment with country goals;
-
Engagement with global health organizations—e.g., WHO and Gavi (the Vaccine Alliance) to establish collaboration opportunities for sharing resources;
-
Engagement with manufacturers of diagnostic equipment and supplies to collaborate with countries to promote and lower costs for newborn screening;
-
Engagement with pharmaceutical companies regarding treatment options for affected babies and children, especially low-cost antibiotics, and generic hydroxyurea for SCD;
-
Exploration of different screening methodology options, such as point-of-care diagnostic technologies to lower cost and program efficiency;
-
Establishment of and prioritizing a minimum list of common conditions to screen infants in Africa in the short term with SCD as the focus;
-
Establishment of country-based and community-based associations working on newborn screening;
-
Training of healthcare workers (doctors, nurses, health educators, genetic counselors, etc.) and public health laboratorians about newborn screening and genetics;
-
Public education about newborn screening and SCD, in particular;
-
Partnership with international maternal and child health, community-based, affected-family and public health organizations that have resources to assist;
-
Continued presentation and publication of pilot screening results;
-
Inclusion and education of community members and families as stakeholders in decision-making processes.
-
Setting up data management systems within the newborn screening programs that can enable evidence-based decision making and longitudinal tracking of SCD patients.
The successful introduction and expansion of newborn screening in Africa will require careful planning and advocacy. Some pilot programs exist with variable approaches, but sustainability requires support from country Ministries of Health (MoH). Helpful partnerships with key stakeholders are needed, including affiliations with other programs of MoH (e.g., maternal and child health, immunization, health education, etc.). In addition, developing collaborative partnerships with other countries for laboratory and clinical support could be utilized.
We have identified the following general challenges to implementing newborn screening for sickle cell diseases (SCD) and other conditions (thalassemias) in Africa:
-
Lack of comprehensive national newborn screening programs;
-
Lack of newborn screening policies and guidelines;
-
Lack of well-trained health workers;
-
Lack of the necessary laboratory infrastructure and associated systems, such as sample transport and laboratory information management systems, to enable testing and dissemination of results;
-
Lack of stable, consistent and sufficient funding.
We recognize the need for establishing collaborations and networks to facilitate the development of sustainable newborn screening programs in all countries.
In order to develop such a collaborative network in Africa, and to move newborn screening forward in our respective countries, we pledge to:
-
Participate in increased communication efforts across the continent including a regional website, biennial regional meetings and annual meetings to share resources and assess each country’s progress;
-
Develop smaller focused topic groups to address important issues (e.g., training, clinical standards of care);
-
Establish a national advisory committee (including representatives of advocacy groups and affected-family organizations) for newborn screening planning;
-
Work with the MoH to gain national support and to address other important issues (e.g., finances, integration with other MoH programs);
-
Ensure standardization of data through the encouragement of the implementation of the common data elements for newborns to facilitate sharing and exchange of data within the continent as well as with the rest of the world;
-
Seek opportunities to train the next generation of health care and public health professionals in new technologies as applied to newborn screening (e.g., molecular genetic methods);
-
Work with affected families and MoH to develop, provide and continually assess templates for culturally-sensitive, multi-media educational materials, and requisite well-trained health educators.
Rights and permissions
About this article
Cite this article
Therrell, B.L., Lloyd-Puryear, M.A., Ohene-Frempong, K. et al. Empowering newborn screening programs in African countries through establishment of an international collaborative effort. J Community Genet 11, 253–268 (2020). https://doi.org/10.1007/s12687-020-00463-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-020-00463-7